BIOCON. Share price

HISTORY AND CERTAIN CORPORATE MATTERSOur Company was incorporated as Biocon India Private Limited onNovember 29 1978 under the Companies Act. The word `Private' wasdeleted from our name under the provisions of Section 43A(2) of theCompanies Act with effect from July 1 1995. Thereafter our Company wasconverted to a private limited company under the provisions of Section43(2A) of the Companies Act with effect from December 21 2000. It wasreconverted into a public limited company on June 18 2001. The name ofour Company was changed from Biocon India Limited to Biocon Limited anda fresh certificate of incorporation consequent on change of name wasissued by the RoC on November 19 2003.Our Corporate StructureOur existing corporate structure is as under:Biocon LimitedClinigene International PrivateLimited (100.00%)Biocon Biopharmaceuticals PrivateLimited (51.00%)Syngene International PrivateLimited (99.99%)Interest of Promoters Directors and Key Managerial PersonnelExcept as stated in ?Related Party Transactions? on page 84 of this RedHerring Prospectus and to the extent of shareholding in our Companythe Promoters do not have any other interest in our business.Our Promoters have significant rights in our Company under the terms ofour Articles of Association. For additional information please referto the section entitled ?Main Provisions of Articles of Association ofBiocon Limited? on page 168 of this Red Herring Prospectus.Except to the extent of their compensation and to the extent of ESOPif any as mentioned on page 165 of this Red Herring Prospectus andtheir shareholding or shareholding of companies they represent theDirectors other than Promoter Directors do not have any otherinterest in our Company. Our Director Mr. John Shaw is the husband ofour Chairman & Managing Director Ms. Kiran Mazumdar-Shaw. OurDirector Prof. Ravi Mazumdar is the brother of our Chairman & ManagingDirector Ms. Kiran Mazumdar-Shaw. Our alternate Director Prof.Catherine Rosenberg is the sister-in-law of our Chairman & ManagingDirector Ms. Kiran Mazumdar-Shaw.The key managerial personnel of our Company do not have any interest inour Company other than to the extent of the remuneration or benefits towhich they are entitled to as per their terms of appointment andreimbursement of expenses incurred by them during the ordinary courseof business and to the extent of the Equity Shares held by them in theCompany if any and options granted to them under the ESOP.